| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| saracatinib | tyrosine-protein kinase abl1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Osteosarcoma[MeSHID:D012516] Hematologic Neoplasms[MeSHID:D019337] |
0.22 | phase 2 | inhibitor |
| saracatinib | tyrosine-protein kinase abl1 | NA | Successful target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.22 | phase 2 | inhibitor |
| saracatinib | proto-oncogene c-src | NA | Successful target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.65 | phase 2 | inhibitor |
| saracatinib | proto-oncogene c-src | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Osteosarcoma[MeSHID:D012516] Hematologic Neoplasms[MeSHID:D019337] |
0.65 | phase 2 | unknown |
| saracatinib | proto-oncogene c-src | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Osteosarcoma[MeSHID:D012516] Hematologic Neoplasms[MeSHID:D019337] |
0.65 | phase 2 | inhibitor |
| saracatinib | proto-oncogene c-src | NA | Successful target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.65 | phase 2 | unknown |
| click here to return to the previous page | ||||||||